Sex Disparities in Hypoxic Vasodilation and Impact of Obesity

EARLY_PHASE1RecruitingINTERVENTIONAL
Enrollment

72

Participants

Timeline

Start Date

March 14, 2023

Primary Completion Date

June 30, 2026

Study Completion Date

June 30, 2026

Conditions
ObesityVasodilationHealthy
Interventions
DRUG

Propranolol Hydrochloride

Regional forearm blockade of β-adrenergic receptors at 20 mcg/dL/min via brachial artery catheter during normoxia and hypoxia exposures

DRUG

Isoproterenol

Dose response (1, 3, 6, and 12 ng/dL/min) regional infusion to assess β-adrenergic receptor responsiveness

DRUG

Phentolamine Mesylate

This infusion will be for 10 min before baseline measurement (12 mcg/dL/min) and continue the infusion at a maintenance rate (5 mcg/dL/min).

DRUG

Norepinephrine

Regional forearm infusion at 8 ng/dL/min via brachial artery catheter during normoxia and hypoxia exposures

Trial Locations (1)

65211

RECRUITING

University of Missouri, Columbia

All Listed Sponsors
lead

University of Missouri-Columbia

OTHER